NGS Gene Testing and Variant Discovery
NGS Gene Testing and Variant Discovery
1 PagesNGS Gene Testing and Variant Discovery Efficient, Scalable and Accessible Solution for MVZ Martinsried, a German-based leading diagnostics company specialised in hereditary dis- eases including inherited cancers as well as non-hereditary solid-tumors, implemented Gold- en Helix’s VarSeq Clinical suite to make NGS gene testing and variant discovery efficient, scalable and accessible by converting NGS data output into customized clinical reports in a timely manner. Since January 2019, MVZ Martinsried is part of Medicover, a leading international Healthcare and Diag- nostic Services company founded in 1995. Medicover provides a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities and laboratories through two divisions
